Whistleblower Suits May Win Broad Endorsement From Supreme Court
This article was originally published in The Pink Sheet Daily
Executive Summary
During oral arguments, justices appear wary of blocking suits based on state data, but pharma says allowing them could create a cottage industry of individuals filing tenuous allegations.